ITM reveals up to $262M debt financing; Caris Life Sciences to go public

Plus, news about Lexeo, TreeFrog Therapeutics, Hansa Biopharma, AbbVie, Elpiscience Biopharmaceuticals, Immutep, Hedera Dx, C4X Discovery, Sanofi, XOMA and BioInvent: ITM Isotope Technologies Munich gets $262.5M from Blue Owl Capital: The radiopharmaceuticals company plans to ...

Related Posts

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

May 27, 2025  0

Movement disorder biotech Vima steps onto scene with $60M

May 29, 2025  0

Novo Nordisk CEO to step down, timeline for successor u...

May 16, 2025  0

Comments

Name

Email

Comment

Post Comment